Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: a GETAID multicentre cohort study

被引：0
|
作者：
Fumery, M. [1 ]
Defrance, A. [2 ]
Roblin, X. [3 ]
Altwegg, R. [4 ]
Caron, B. [5 ]
Hebuterne, X. [6 ]
Carmen, S. [7 ]
Meyer, A. [8 ]
Nachury, M. [9 ]
Laharie, D. [10 ]
Nancey, S. [11 ]
Le Berre, C. [12 ]
Serrero, M. [13 ]
Geyl, S. [14 ]
Gilletta, C. [15 ]
Soune, P. Ah [16 ]
Duveau, N. [17 ]
Uzza, M. [18 ]
Abitbol, V. [19 ]
Biron, A. [20 ]
Minh, M. L. Tran [21 ]
Paupard, T. [22 ]
Vuitton, L. [23 ]
Elgharabawy, Y. [2 ]
Peyrin-Biroulet, L. [5 ]
机构：
[1] Amiens Univ Hosp, Gastroenterol, Amiens 1, France
[2] GETAID, Paris, France
[3] St Etienne Univ Hosp, Gastroenterol, St Etienne, France
[4] Montpellier Univ Hosp, Gastroenterol, Montpellier, France
[5] Nancy Univ Hosp, Gastroenterol, Nancy, France
[6] Nice Univ Hosp, Gastroenterol, Nice, France
[7] GH Ambroise Pare Hartmann, Gastroenterol, Neuilly, France
[8] Kremlin Bicetre, Gastroenterol, Paris, France
[9] Lille Univ Hosp, Gastroenterol, Lille, France
[10] Bordeaux Univ Hosp, Gastroenterol, Bordeaux, France
[11] Lyon Univ Hosp, Gastroenterol, Lyon, France
[12] Nantes Univ Hosp, Gastroenterol, Nantes, France
[13] Marseille Univ Hosp, Gastroenterol, Marseille, France
[14] Limoges Univ Hosp, Gastroenterol, Limoges, France
[15] Toulouse Univ Hosp, Gastroenterol, Toulouse, France
[16] Toulon Hosp, Gastroenterol, Toulon, France
[17] Roubaix Hosp, Gastroenterol, Roubaix, France
[18] Hop Mondor, Gastroenterol, Creteil, France
[19] Hop Cochin, Paris, France
[20] Reims Univ Hosp, Gastroenterol, Reims, France
[21] St Louis Hosp, Gastroenterol, Paris, France
[22] Dunkerque Hosp, Gastroenterol, Dunkerque, France
[23] Besancon Univ Hosp, Gastroenterol, Besancon, France
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P638
引用
收藏
页码：770 / 770
页数：1
相关论文
共 50 条
  • [1] Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: A GETAID multicentre cohort study
    Fumery, Mathurin
    Defrance, Antoine
    Roblin, Xavier
    Altwegg, Romain
    Caron, Benedicte
    Hebuterne, Xavier
    Stefanescu, Carmen
    Meyer, Antoine
    Nachury, Maria
    Laharie, David
    Nancey, Stephane
    Le Berre, Catherine
    Serrero, Melanie
    Geyl, Sophie
    Giletta, Cyrielle
    Ah-Soune, Philippe
    Duveau, Nicolas
    Uzzan, Mathieu
    Abitbol, Vered
    Biron, Amelie
    My-Linh Tran-Minh
    Paupard, Thierry
    Vuitton, Lucine
    Elgharabawy, Yasmine
    Peyrin-Biroulet, Laurent
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (04) : 426 - 434
  • [2] Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study
    Amiot, Aurelien
    Filippi, Jerome
    Abitbol, Vered
    Cadiot, Guillaume
    Laharie, David
    Serrero, Melanie
    Altwegg, Romain
    Bouhnik, Yoram
    Peyrin-Biroulet, Laurent
    Gilletta, Cyrielle
    Roblin, Xavier
    de Chambrun, Guillaume Pineton
    Vuitton, Lucine
    Bourrier, Anne
    Nancey, Stephane
    Gornet, Jean-Marc
    Nahon, Stephane
    Bouguen, Guillaume
    Viennot, Stephanie
    Pariente, Benjamin
    Fumery, Mathurin
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (11) : 1039 - 1046
  • [3] Efficacy and Safety of Infliximab Retreatment in Crohn's Disease: A Multicentre, Prospective, Observational Cohort (REGAIN) Study from the GETAID
    Boschetti, Gilles
    Nachury, Maria
    Laharie, David
    Roblin, Xavier
    Gilletta, Cyrielle
    Aubourg, Alexandre
    Bourreille, Arnaud
    Zallot, Camille
    Hebuterne, Xavier
    Buisson, Anthony
    Grimaud, Jean-Charles
    Bouhnik, Yoram
    Allez, Matthieu
    Altwegg, Romain
    Viennot, Stephanie
    Vuitton, Lucine
    Carbonnel, Franck
    Paul, Stephane
    Desseaux, Kristell
    Lambert, Jerome
    Peyrin-Biroulet, Laurent
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (09): : 1482 - 1490
  • [4] Effectiveness and safety of subcutaneous infliximab in perianal Crohn's disease: a multicentre cohort study
    Andre, M.
    Kirchgesner, J.
    Laharie, D.
    Guillo, L.
    Abramowitz, L.
    Seksik, P.
    Nachury, M.
    Fumery, M.
    Amil, M.
    Nancey, S.
    Le Berre, C.
    Moussata, D.
    Buisson, A.
    Fathallah, N.
    Gilletta, C.
    Uzzan, M.
    Duveau, N.
    Peyrin-Biroulet, L.
    Nahon, S.
    Savoye, G.
    Charkaoui, M.
    Vicaut, E.
    Vuitton, L.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1577 - I1577
  • [5] Long-term outcomes of risankizumab in Crohn's disease: a multicenter GETAID Study
    Fumery, M.
    Caron, B.
    Hebuterne, X.
    Altwegg, R.
    Roblin, X.
    Stefanescu, C.
    Meyer, A.
    Nachury, M.
    Laharie, D.
    Le Berre, C.
    Guillo, L.
    Biron, A.
    Caillo, L.
    Buisson, A.
    Nancey, S.
    Uzzan, M.
    Vuitton, L.
    Gilletta, C.
    Geyl, S.
    Simon, M.
    Kirchgesner, J.
    Soune, P. Ah
    Duveau, N.
    Vidon, M.
    Abitbol, V.
    Paupard, T.
    Defrance, A.
    Peyrin-Biroulet, L.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1676 - I1676
  • [6] Crohn's Disease: Risankizumab as Induction- and Maintenance Therapy
    Franke, Katharina
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (17) : 1085 - 1085
  • [7] Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with real-world ulcerative colitis: A GETAID multicentre cohort study
    Fumery, M.
    Filippi, J.
    Abitbol, V.
    Biron, A.
    Laharie, D.
    Serrero, M.
    Altwegg, R.
    Bouhnik, Y.
    Peyrinbiroulet, L.
    Gilletta, C.
    Roblin, X.
    de Chambrun, G. Pineton
    Vuitton, L.
    Bourrier, A.
    Nancey, S.
    Gornet, J. M.
    Nahon, S.
    Bouguen, G.
    Viennot, S.
    Pariente, B.
    Amiot, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S486 - S487
  • [8] Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study
    Alsoud, Dahham
    Sabino, Joao
    Franchimont, Denis
    Cremer, Anneline
    Busschaert, Julie
    D'Heygere, Francois
    Bossuyt, Peter
    Vijverman, Anne
    Vermeire, Severine
    Ferrante, Marc
    [J]. INFLAMMATORY BOWEL DISEASES, 2024,
  • [9] Effectiveness and Safety of Risankizumab Induction Therapy in Crohn's Disease: Prospective Real-World Experience in a Large Tertiary Center
    Zinger, Adar
    Choi, David K.
    Choi, Natalie K.
    Garcia, Nicole M.
    Cohen, Russell D.
    Dalal, Sushila
    Cleveland, Noa Krugliak
    Rubin, David T.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S834 - S834
  • [10] Effectiveness and safety of ustekinumab induction therapy in ulcerative colitis: A GETAID real-world cohort study
    Amiot, A.
    Vered, A.
    Filippi, J.
    Cadiot, G.
    Laharie, D.
    Melanie, S.
    Altwegg, R.
    Bouhnik, Y.
    Peyrin-biroulet, L.
    Gilletta, C.
    Roblin, X.
    de Chambrun, G. Pineton
    Vuitton, L.
    Bourrier, A.
    Nancey, S.
    Gornet, J. M.
    Nahon, S.
    Bouguen, G.
    Viennot, S.
    Benjamin, P.
    Fumery, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S579 - S579
12345